Patents by Inventor Peter Jones

Peter Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND APPARATUS FOR A COLORLESS DIRECTIONLESS AND SUPER-CHANNEL CONTENTIONLESS (CDSC) OPTICAL NETWORK ARCHITECTURE
    Publication number: 20190306595
    Abstract: In some embodiments, a system includes a super-channel multiplexer (SCM) and an optical cross connect (OXC) switch. The SCM is configured to multiplex a set of optical signals into a super-channel optical signal with a wavelength band. The OXC switch is configured to be operatively coupled to the SCM and a reconfigurable optical add-drop multiplexer (ROADM) degree. The OXC switch is configured to be located between the SCM and the ROADM degree and the OXC switch, the SCM, and the ROADM degree are configured to be included in a colorless, directionless, and contentionless (CDC) optical network. The OXC switch is configured to switch, based on the wavelength band, the super-channel optical signal to an output port from a set of output ports of the OXC switch. The OXC switch is configured to transmit the super-channel optical signal from the output port to the ROADM degree.
    Type: Application
    Filed: June 19, 2019
    Publication date: October 3, 2019
    Applicant: Juniper Networks, Inc.
    Inventors: Kevan Peter JONES, Robert William KEYS
  • Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
    Patent number: 10426135
    Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: October 1, 2019
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek, Michael L. Vazquez, Goran Mattias Wennerstal, Li Xing, Edouard Zamaratski, Liying Zhang, Rayomand Jal Unwalla
  • Cyclic Peptides As C5a Receptor Antagonists
    Publication number: 20190270778
    Abstract: The invention relates to cyclic peptide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to cyclic peptide C5a receptor antagonists of formula (Ia) or formula (Ib), or pharmaceutically acceptable salts thereof, wherein R1a, R1b, R2, R3 and R4 areas defined in the description. C5a receptor antagonists are potentially useful in the treatment of a wide range of 1 disorders, including inflammatory disorders and immune disorders.
    Type: Application
    Filed: July 17, 2017
    Publication date: September 5, 2019
    Applicant: Pfizer Inc.
    Inventors: Ye Che, Yiqing Feng, Matthew Merrill Hayward, David Hepworth, Peter Jones, Kaila Neelu, Nikolaos Papaioannou
  • LABELED SECURITY FOR CONTROL FLOW INSIDE EXECUTABLE PROGRAM CODE
    Publication number: 20190266322
    Abstract: A method includes loading each section of an executable program code into a respective page of memory, configuring permissions for a first page including a first section of the executable program code to enable execution of the first section loaded into the first page. The first section associated with a first label. The method also includes configuring permissions for a second page of the memory including a second section of the executable program code to disable execution of the second section loaded into the second page. The second section associated with a second label. Responsive to a determination that a transition from the first section to the second section is allowed during execution of the executable program code, the method also includes changing the permissions of the second page to enable execution of the second section of the executable program code.
    Type: Application
    Filed: February 28, 2018
    Publication date: August 29, 2019
    Inventors: Peter Jones, Adam Jackson
  • CAST-IN-HEAD EGR CROSSOVER TUBE WITH INTEGRAL VENTURI TUBE FOR FLOW MEASUREMENTS
    Publication number: 20190264626
    Abstract: A cylinder head defines an EGR crossover tube integrally formed in the cylinder head. The EGR crossover tube includes a first end fluidly coupled to an exhaust port of an engine. A second end is fluidly coupled to an intake port of the engine. A Venturi tube configuration is positioned between the first and second ends. A first sensor port extends through the cylinder head to the EGR crossover tube. The first sensor port is positioned at a restriction of the Venturi tube configuration. A second sensor port extends through the cylinder head to the EGR crossover tube. The second sensor port is positioned proximate the first end. A differential pressure sensor includes a first pressure sensor positioned in the first sensor port and a second pressure sensor positioned in the second sensor port.
    Type: Application
    Filed: September 19, 2017
    Publication date: August 29, 2019
    Applicant: CUMMINS INC.
    Inventors: James A. Dods, John Jerl Purcell, John Peter Jones, John R. Anderson, Paul Andrew Leggott, Graham Dowson
  • Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof
    Patent number: 10385036
    Abstract: The present invention provides sulfonamide-substituted indoles and Methods of Use Thereof-substituted pyrrolopyridines, pharmaceutical compositions thereof methods of modulating RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such indoles and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: August 20, 2019
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek, Michael L. Vazquez, Goran Mattias Wennerstal, Li Xing, Edouard Zamaratski, Liying Zhang, Rayomand J. Unwalla
  • Dialysis system with radio frequency device within a magnet assembly for medical fluid sensing and concentration determination
    Patent number: 10371775
    Abstract: This disclosure relates to medical fluid sensors and related systems and methods. In certain aspects, a method includes using a medical fluid pump of a medical fluid pumping machine, such as a hemodialysis machine, to deliver medical fluid to a first portion of a cartridge that is positioned within a magnetic field, exciting atoms in the medical fluid in the first portion of the cartridge by applying radio frequency energy to the medical fluid in the first portion of the cartridge, receiving radio frequency energy generated by the excited atoms in the medical fluid in the first portion of the cartridge, and determining a concentration of a substance in the medical fluid based on the received radio frequency energy generated by the excited atoms in the medical fluid in the first portion of the cartridge.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: August 6, 2019
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Ross Peter Jones, Martin Joseph Crnkovich, Fei Wang, Thomas Irvin Folden, Lynn Jensen, Shashikant Dattatraya Kalaskar
  • Methods and apparatus for a colorless directionless and super-channel contentionless (CDsC) optical network architecture
    Patent number: 10368149
    Abstract: In some embodiments, a system includes a super-channel multiplexer (SCM) and an optical cross connect (OXC) switch. The SCM is configured to multiplex a set of optical signals into a super-channel optical signal with a wavelength band. The OXC switch is configured to be operatively coupled to the SCM and a reconfigurable optical add-drop multiplexer (ROADM) degree. The OXC switch is configured to be located between the SCM and the ROADM degree and the OXC switch, the SCM, and the ROADM degree are configured to be included in a colorless, directionless, and contentionless (CDC) optical network. The OXC switch is configured to switch, based on the wavelength band, the super-channel optical signal to an output port from a set of output ports of the OXC switch. The OXC switch is configured to transmit the super-channel optical signal from the output port to the ROADM degree.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: July 30, 2019
    Assignee: Juniper Networks, Inc.
    Inventors: Kevan Peter Jones, Robert William Keys
  • Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
    Patent number: 10336748
    Abstract: The present invention provides methoxy-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 2, 2019
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek, Michael L. Vazquez, Goran Mattias Wennerstal, Li Xing, Edouard Zamaratski, Liying Zhang, Rayomand J. Unwalla
  • METHODS AND APPARATUS FOR A COLORLESS DIRECTIONLESS AND SUPER-CHANNEL CONTENTIONLESS (CDSC) OPTICAL NETWORK ARCHITECTURE
    Publication number: 20190191232
    Abstract: In some embodiments, a system includes a super-channel multiplexer (SCM) and an optical cross connect (OXC) switch. The SCM is configured to multiplex a set of optical signals into a super-channel optical signal with a wavelength band. The OXC switch is configured to be operatively coupled to the SCM and a reconfigurable optical add-drop multiplexer (ROADM) degree. The OXC switch is configured to be located between the SCM and the ROADM degree and the OXC switch, the SCM, and the ROADM degree are configured to be included in a colorless, directionless, and contentionless (CDC) optical network. The OXC switch is configured to switch, based on the wavelength band, the super-channel optical signal to an output port from a set of output ports of the OXC switch. The OXC switch is configured to transmit the super-channel optical signal from the output port to the ROADM degree.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 20, 2019
    Applicant: Juniper Networks, Inc.
    Inventors: Kevan Peter JONES, Robert William KEYS
  • HIGH DEGREE OF FREEDOM RISER TENSIONER SYSTEM
    Publication number: 20190178040
    Abstract: A riser tensioner system has a riser support device, an actuator, and a bearing assembly disposed between the riser support device and the actuator. The bearing assembly is configured to provide at least five degrees of freedom of movement of the riser support device relative to the actuator.
    Type: Application
    Filed: August 29, 2016
    Publication date: June 13, 2019
    Inventors: Peter JONES, Zachary FUHRER, Jonathan OWENS, Gregg CUNE
  • Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof
    Publication number: 20190150401
    Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
    Type: Application
    Filed: February 6, 2019
    Publication date: May 23, 2019
    Applicant: Pfizer Inc.
    Inventors: Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek, Michael L. Vazquez, Goran Mattias Wennerstal, Li Xing, Edouard Zamaratski, Liying Zhang, Rayomand Jal Unwalla
  • RORC2 INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20190144429
    Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
    Type: Application
    Filed: January 30, 2019
    Publication date: May 16, 2019
    Applicant: Pfizer Inc.
    Inventors: Mark Edward Schnute, Gõran Mattias Wennerstål, James Robert Blinn, Neelu Kaila, James Richard Kiefer, JR., Scot Richard Mente, Ravi G. Kurumbail, Marvin Jay Meyers, Atli Thorarensen, Li Xing, Christoph Wolfgang Zapf, Edouard Zamaratski, Andrew Christopher Flick, Peter Jones
  • Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
    Patent number: 10287258
    Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: May 14, 2019
    Assignee: ASTRAZENECA AB
    Inventors: Hans Roland Lonn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
  • Wavelength provisioning for customer premise equipment (CPE) in dense wavelength-division multiplex (DWDM) networks
    Patent number: 10277353
    Abstract: A system includes a first communication device and a second communication device in communication with the first communication device via an Ethernet connection. The first communication device is configured to transmit, via the Ethernet connection toward the second communication device, an Ethernet signal including information of a designated wavelength from a dense wavelength division multiplexing (DWDM) scheme to be used by the second communication device. The second communication device is configured to transmit an optical signal at the designated wavelength to the first communication device in response to receiving the Ethernet signal.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: April 30, 2019
    Assignee: Juniper Networks, Inc.
    Inventors: Gert Grammel, Kevan Peter Jones
  • OPTICAL PROTECTION SWITCH WITH BROADCAST MULTI-DIRECTIONAL CAPABILITY
    Publication number: 20190103934
    Abstract: An apparatus includes a first reconfigurable optical add/drop multiplexer (ROADM) to receive a first optical signal and a second ROADM to receive a second optical signal. The apparatus also includes a reconfigurable optical switch that includes a first switch, switchable between a first state and a second state, to transmit the first optical signal at the first state and block the first optical signal at the second state. The reconfigurable optical switch also includes a second switch, switchable between the first state and the second state, to transmit the second optical signal at the first state and block the second optical signal at the second state. The reconfigurable optical switch also includes an output port to transmit an output signal that is a sum of possible optical signals transmitted through the first switch and the second switch.
    Type: Application
    Filed: September 30, 2017
    Publication date: April 4, 2019
    Applicant: Juniper Networks, Inc.
    Inventor: Kevan Peter JONES
  • OPTICAL MULTICAST SWITCH WITH BROADCAST CAPABILITY
    Publication number: 20190103935
    Abstract: An apparatus includes a first input port, a first switch, and a second switch. The first switch and the second input port are in optical communication with the first input port. The apparatus also includes a second input port, a third switch, and a fourth switch. The third switch and the fourth switch are in optical communication with the second input port. Each switch is switchable between a first state to pass optical signals and a second state to block optical signals. The apparatus also includes a first combiner in optical communication with the first input port via the first switch and the second input port via the third switch. The apparatus also includes a second combiner in optical communication with the first input port via the second switch and the second input port via the fourth switch.
    Type: Application
    Filed: September 30, 2017
    Publication date: April 4, 2019
    Applicant: Juniper Networks, Inc.
    Inventor: Kevan Peter JONES
  • Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof
    Patent number: 10227346
    Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: March 12, 2019
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek, Michael L. Vazquez, Goran Mattias Wennerstal, Li Xing, Edouard Zamaratski, Liying Zhang, Rayomand Jal Unwalla
  • GIMBAL SYSTEM
    Publication number: 20190009866
    Abstract: A gimbal (200) has an intermediate plate (202), a first plate (204) offset from the intermediate plate (202) in a first direction, a first bearing (208) having a first rotational axis connected between the intermediate plate (202) and the first plate (204), a second plate (206) offset from the intermediate plate (202) in a second direction opposite the first direction, and a second bearing (210) having a second rotational axis connected between the intermediate plate (202) and the second plate (206).
    Type: Application
    Filed: September 1, 2016
    Publication date: January 10, 2019
    Applicant: LORD Corporation
    Inventor: Peter JONES
  • Low latency distributed storage service
    Patent number: 10140312
    Abstract: A low latency metadata subsystem for file systems in low latency (LL) mode in a distributed file storage service (DFSS). An LL server (LLS) may receive metadata requests from an access node of the DFSS. For read operations, the LLS may check a local cache of metadata and, for cache hits, retrieve the metadata from the cache. For cache misses, the metadata may be fetched from the storage subsystem of the DFSS and cached. For write operations, the LLS may write entries into a journal for the file system and notify the access node after the journal entries are committed to the journal; the journal entries are asynchronously committed in the storage subsystem. The access node may communicate with the storage subsystem to perform data reads and writes for the LL file system.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: November 27, 2018
    Assignee: Amazon Technologies, Inc.
    Inventors: Jacob A. Strauss, Mark Allen Fogleman, Edward William Naim, Jacob David Luszcz, Michael Robert Frasca, Daniel Nussbaum, Peter Jones, Xiaobin Wu, John McClain, Neal John Charbonneau, Wayne William Duso